Home › Funds › Sofinnova Investments, Inc. › DSGN
Sofinnova Investments, Inc. position in DSGN
DESIGN THERAPEUTICS INC · Health Care
Sofinnova Investments, Inc. reported holding 865,135 shares of DSGN (DESIGN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$12.5M, representing 0.67% of its reported portfolio and ranking #35 among its reported holdings. Sofinnova Investments, Inc. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s DSGN position evolved
Sofinnova Investments, Inc. first disclosed a stake in DSGN in Q2 2026 at 865,135 shares (US$12.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 865.13K | $12.52M | New |
About DSGN and 13F data
DSGN (DESIGN THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in DSGN — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$94.4M), Logos Global Management LP (US$43.4M), BAKER BROS. ADVISORS LP (US$38.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DSGN
- SR ONE CAPITAL MANAGEMENT, LP 6.53M sh · $94.44M · Q2 2026
- Logos Global Management LP 3.00M sh · $43.41M · Q2 2026
- BAKER BROS. ADVISORS LP 2.68M sh · $38.76M · Q2 2026
- Trails Edge Capital Partners, LP 2.00M sh · $28.96M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.81M sh · $26.19M · Q2 2026
- Vivo Capital, LLC 1.61M sh · $23.34M · Q2 2026
- Almitas Capital LLC 1.03M sh · $14.86M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 282.56K sh · $4.09M · Q2 2026
- KVP Capital Advisors, LP 185.00K sh · $2.68M · Q2 2026
- Elmind Capital, LP 107.90K sh · $1.56M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held DSGN?
Sofinnova Investments, Inc. has disclosed DSGN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Sofinnova Investments, Inc.'s current position in DSGN?
As of Q2 2026, Sofinnova Investments, Inc. holds 865.13K shares of DSGN (DESIGN THERAPEUTICS INC), valued at $12.52M, representing 0.67% of its reported portfolio and ranking #35.
Has Sofinnova Investments, Inc. been buying or selling DSGN?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. newly opened its position in DSGN.
Which other funds hold DSGN?
Other major institutional holders of DSGN include SR ONE CAPITAL MANAGEMENT, LP, Logos Global Management LP, BAKER BROS. ADVISORS LP, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.